NICE greenlights Pfizer’s Talzenna for NHS use
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Talzenna (talazoparib) in a step forward for…
All articles by Annabel Kartal Allen
Annabel Kartal Allen
Annabel Kartal-Allen is a reporter for Clinical Trials Arena, Pharmaceutical Technology and Medical Device Network based in London, UK. Annabel holds interests in oncology, neurology and metabolic diseases. She has previous experience reporting for both the pharmaceutical and nutraceutical industries, and holds a BSc in Biology from the University of Sussex. Contact Annabel
-
-
High-dose biologic delivery to become industry standard
As the pharmaceutical industry progresses further into the age of personalised medicine, next-generation, targeted and disease-modifying biologics are becoming increasingly…
-
BMS bets on Janux’s novel solid tumour therapy through $850m deal
Bristol Myers Squibb (BMS) has added to its oncology pipeline through an exclusive global licensing agreement with Janux Therapeutics. This…
-
Heart disease and stroke deaths take a downturn, AHA report reveals
A new report from the American Heart Association (AHA) has found that US cardiovascular disease (CVD)-related deaths declined between 2022…
-
Pfizer and Novavax ink $530m vaccine delivery licensing deal
Pfizer has signed a deal worth up to $530m with US-based vaccine technology company Novavax. This agreement will see Pfizer…
-
GSK acquires RAPT Therapeutics for $2.2bn
In a bid to bolster its immunology portfolio, GSK is acquiring food allergy specialist RAPT Therapeutics for up to $2.2bn.…
-
FDA prevails over EMA in 2025 novel drug approvals
The US Food and Drug Administration (FDA) has once again bested the European Medicines Agency (EMA) in terms of new…
-
UK’s MHRA gives high-dose Wegovy the go-ahead in obesity
In a landmark move for UK patients with obesity, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the…
-
Novo Nordisk Foundation pours $850m into European life sciences economy
The Novo Nordisk Foundation has donated Dkr5.5bn ($850m) to the BioInnovation Institute (BII) to bolster the competitiveness of the European…
-
FDA and EMA release collaborative AI framework for drug development
In a bid to optimise the use of AI in drug development, US and European regulators have banded together to…